Back
Oracle Corp. Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Sell
37
ORCL
Oracle Corp.
Last Price:
$221.03
Seasonality Move:
12.46%
Buy
53
VKTX
Viking Therapeutics, Inc.
Last Price:
$37.35
Seasonality Move:
78.5%
Sell
37
Oracle Corp. (ORCL)
is a Sell
Is Oracle Corp. a Buy, Sell or Hold?
-
The current Oracle Corp. [ORCL] share price is $217.58. The Score for ORCL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ORCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Viking Therapeutics, Inc. (VKTX)
is a Buy
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $38.55. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ORCL Stock Price Chart
What is Oracle Corp.'s stock price today?
-
The Oracle Corp. share price today is $217.58The current trend is relatively stagnant and ORCL is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $38.55The current trend is moderately bullish and VKTX is experiencing slight selling pressure.
ORCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.22 | Sell |
| Relative Strength Index (14 RSI): | 44.28 | Sell |
| Chaikin Money Flow: | 8398932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.29 - 242.11) | Sell |
| Bollinger Bands (100): | (223.5 - 288.94) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.28 | Buy |
| Relative Strength Index (14 RSI): | 58.65 | Buy |
| Chaikin Money Flow: | -825700 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.92 - 38.78) | Buy |
| Bollinger Bands (100): | (27.31 - 37.37) | Buy |
ORCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 205.7 | Buy |
| 20-day SMA: | 215.24 | Buy |
| 50-day SMA: | 254.62 | Sell |
| 200-day SMA: | 211.87 | Buy |
| 8-day EMA: | 209.8 | Buy |
| 20-day EMA: | 218.9 | Sell |
| 50-day EMA: | 239.33 | Sell |
| 200-day EMA: | 222.51 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.19 | Buy |
| 20-day SMA: | 36.94 | Buy |
| 50-day SMA: | 34.59 | Buy |
| 200-day SMA: | 29.8 | Buy |
| 8-day EMA: | 36.24 | Buy |
| 20-day EMA: | 30.5 | Buy |
| 50-day EMA: | 18.84 | Buy |
| 200-day EMA: | 6.07 | Buy |
Oracle Corp. Earnings Growth & ORCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.82 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Oracle Corp. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||